Vanda Pharmaceuticals (VNDA) Gross Profit (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.04% |
| Dec 31, 2025 | 0.15% |
| Sep 30, 2025 | 6.92% |
| Jun 30, 2025 | 7.17% |
| Mar 31, 2025 | -8.05% |
| Dec 31, 2024 | 12.18% |
| Sep 30, 2024 | -5.53% |
| Jun 30, 2024 | 8.45% |
| Mar 31, 2024 | 5.29% |
| Dec 31, 2023 | 16.95% |
| Sep 30, 2023 | -15.99% |
| Jun 30, 2023 | -26.28% |
| Mar 31, 2023 | -0.89% |
| Dec 31, 2022 | -1.28% |
| Sep 30, 2022 | 1.14% |
| Jun 30, 2022 | 6.98% |
| Mar 31, 2022 | -11.74% |
| Dec 31, 2021 | -2.39% |
| Sep 30, 2021 | 3.20% |
| Jun 30, 2021 | 8.29% |
| Mar 31, 2021 | -7.51% |
| Dec 31, 2020 | 12.55% |
| Sep 30, 2020 | -3.46% |
| Jun 30, 2020 | 6.76% |
| Mar 31, 2020 | -3.50% |
| Dec 31, 2019 | 3.80% |
| Sep 30, 2019 | 0.02% |
| Jun 30, 2019 | 23.69% |
| Mar 31, 2019 | -10.08% |
| Dec 31, 2018 | 7.50% |
| Sep 30, 2018 | 4.58% |
| Jun 30, 2018 | 7.96% |
| Mar 31, 2018 | -1.15% |
| Dec 31, 2017 | 7.26% |
| Sep 30, 2017 | -1.91% |
| Jun 30, 2017 | 12.32% |
| Mar 31, 2017 | 1.33% |
| Dec 31, 2016 | 4.70% |
| Sep 30, 2016 | 6.63% |
| Jun 30, 2016 | 8.16% |
| Mar 31, 2016 | 6.34% |
| Dec 31, 2015 | 17.61% |
| Sep 30, 2015 | 0.08% |
| Jun 30, 2015 | 27.32% |
| Mar 31, 2015 | 16.66% |
| Dec 31, 2014 | 4.33% |
| Sep 30, 2014 | 32.02% |
| Dec 31, 2010 | -166.26% |
| Sep 30, 2010 | 27,769.23% |